BioNTech with continued late-stage pipeline progress with candidates across immunomodulators, antibody-drug conjugates and mRNA immunotherapiesExpected 2026 oncology milestones include seven ...

In the latest trading session, Strategy (MSTR) closed at $158.24, marking a -1.33% move from the previous day. This move lagged the S&P 500's daily gain of 0.79%. On the other hand, the Dow registered ...

Last year, a team of American diplomats from the State Department’s Global Engagement Center traveled to two dozen countries and signed a series of memoranda. Along with their counterparts in places ...

Evolution Petroleum (EPM) +1.3% in Thursday's trading as Roth Capital resumed coverage with a Buy rating and $5 price target, saying the company's diversified production mix, focus on acquiring mature ...

While Washington’s gaze is fixed on the Caribbean, a quieter but no less important shift is taking place across the top of the world. Canada and the European Union have signed a new Security and ...

Nokia announces new strategy, evolution of its operating model, new long-term financial target, strategic KPIs and changes to its Group Leadership Team Espoo, Finland – Nokia is holding its Capital ...

Discover why some of the world’s most famous innovations didn’t come from the boardroom. Learn how everyday employees can spark breakthroughs you might be overlooking. What do Post-it notes, Gmail and ...

The price of the world's largest cryptocurrency recently traded below $92,000 for the first time in months. At least one backer is still buying in: Strategy said it bought an additional 8,178 bitcoin ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple ...

Strategy Inc (NASDAQ: MSTR) shares are trading lower Thursday in tandem with a drop in Bitcoin (CRYPTO: BTC), with crypto-linked stocks declining as traders debate whether Bitcoin’s typical four-year ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...